Back
Weiming Pharma Case Ends; Ex-Chairman to Repay 12.75M RMB
Back
Stock News
Themes
Weiming Pharma Case Ends; Ex-Chairman to Repay 12.75M RMB
Weiming Pharma Case Ends; Ex-Chairman to Repay 12.75M RMB
Edgen Stock
·
Jan 02 2026, 11:54
Share to
Share to
Copy link
source:
[1] Weiming Pharmaceutical Equity Case Appellate Ruling Changed: Embezzlement Charge Dropped, Prison Terms and Fines Significantly Reduced
Recommend
Enterprise Products Partners Nears Financial Inflection Point, Poised for Enhanced Shareholder Returns
Nov 28 2025, 10:17
US-China AI Rivalry Enters New Phase Focused on Compute Power and Cybersecurity
Nov 28 2025, 10:17
Enterprise Products Partners Nears Financial Inflection Point, Poised for Enhanced Shareholder Returns
Nov 28 2025, 10:17